Virtual Medicinal Product (VMP) - Rizatriptan 5mg tablets

Name Details

Name Start Date End Date
Name Current Name Rizatriptan 5mg tablets Start Date 21-10-2002 End Date

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1.0
UDFS UOM
tablet
Unit Dose UOM
tablet

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Oral
Form
Oral tablet
Ontology Form/Route
tablet.oral
Name Basis
rINN - Recommended International Non-proprietary

Codes

ATC Code
N02CC04
BNF Start Date End Date
Current BNF 04070401 Start Date 04-04-2022 End Date
Previous BNF 04070401 Start Date 22-02-2005 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
42110811000001102 28-07-2023
322829003 21-10-2002 27-07-2023

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Rizatriptan benzoate Based on Base Substance Rizatriptan 5 mg

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
3 tablet
6 tablet 2826 Part VIIIA Category A